Skip to content

Author

M. Reibaldi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

From Intermediate AMD to Geographic Atrophy: Biomarkers, Endpoints, and a Roadmap for Next-Generation Clinical Trials.

Age-related macular degeneration (AMD) is a leading cause of irreversible legal blindness worldwide. Treatments exist for late-stage AMD, but none exists for the intermediate stage (iAMD), which precedes significant vision loss. A therapy tested in iAMD would aim to prevent or slow progression to late-stage disease, me...

Alessandro Berni, P. Rosenfeld, D. Bacherini et al. · 0 citations
Review Open access Aug 2026

Macular atrophy in neovascular age-related macular degeneration: Prevalence, risk factors, imaging features, and clinical implications.

Current evidence on the definition, epidemiology, risk factors, imaging features, and functional consequences of MA in nAMD are summarized and standardized definitions, multimodal imaging, and predictive models are guided to guide personalized management and develop therapies targeting atrophy.

Xue-Nan Zhuang, Chiara Olivieri, G. Neri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.